The SPRY domain of TRIM21 mainly interacts with SREBF1, and TRIM21 delivers K63-ubiquitin to SREBF1, leading to the recognition and degradation of SREBF1 by the proteasomes, which may further attenuate the lipogenesis of RCC cells. This evidence concerns the gene TRIM21 and renal cell carcinoma.